After Jerusalem signed binding term sheet for purchase of drug, CEO of Arcturus Therapeutics says Phase 3 study needs to be held in location with substantial number of cases

TV reports country to buy four million units of drug made by Arcturus Therapeutics and Singapore's Duke-NUS medical school, recently granted permission to begin clinical trails